Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 18, 2003
Oral citicoline treatment improves visual pathway function in glaucomaRobert Rejdak, Jerzy Toczołowski, Jacek Kurkowski, et al.Neurologia I Neurochirurgia Polska|March 1, 2005
[Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis]Jacek Kurzepa, Halina Bartosik-Psujek, Danuta Suchozebrska-Jesionek, et al.Neurologia I Neurochirurgia Polska|July 17, 2007
[Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)]Anna Jamroz-Wiśniewska, Ewa Papuć, Halina Bartosik-Psujek, et al.Neurologia I Neurochirurgia Polska|December 3, 2014
Disappearance of white matter lesions on MRI and clinical recovery after initiating antiretroviral therapy in a case of HIV infection presenting as spastic paraparesisAnna Jamroz-Wiśniewska, Jacek Jaworski, Dorota Suszek, et al.Neuroscience Letters|October 3, 2002
Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patientsKonrad Rejdak, Halina Bartosik-Psujek, Beata Dobosz, et al.Clinical Neurology and Neurosurgery|July 28, 2009
B-type natriuretic peptide as a marker of subclinical heart injury during mitoxantrone therapy in MS patients--preliminary studyPiotr Luchowski, Krystyna Mitosek-Szewczyk, Halina Bartosik-Psujek, et al.Neurologia I Neurochirurgia Polska|June 4, 2004
[Open trial of the effectiveness of interferon beta 1a (Avonex) in the treatment of multiple sclerosis in Poland: MRI results]Małgorzata Siger-Zajdel, Magdalena Lewańska, Krzysztof Zaleski, et al.Journal of the Neurological Sciences|July 10, 2013
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosisKrystyna Mitosek-Szewczyk, Jacek Tabarkiewicz, Barbara Wilczynska, et al.Epilepsia|April 19, 2012
Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injuryKonrad Rejdak, Jens Kuhle, Stephan Rüegg, et al.Journal of the Peripheral Nervous System : JPNS|June 21, 2013
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)Jean-Marc Léger, Jan L De Bleecker, Claudia Sommer, et al.Pageof 9